25 XP   0   0   10

Acrux Ltd
Buy, Hold or Sell?

Let's analyse Acrux together

PenkeI guess you are interested in Acrux Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Acrux Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Acrux Ltd

I send you an email if I find something interesting about Acrux Ltd.

Quick analysis of Acrux (30 sec.)










What can you expect buying and holding a share of Acrux? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-7.0%

For what price can you sell your share?

Current Price per Share
A$0.08
Expected price per share
A$0.068 - A$0.099
How sure are you?
50%

1. Valuation of Acrux (5 min.)




Live pricePrice per Share (EOD)

A$0.08

Intrinsic Value Per Share

A$-0.27 - A$0.55

Total Value Per Share

A$-0.24 - A$0.58

2. Growth of Acrux (5 min.)




Is Acrux growing?

Current yearPrevious yearGrowGrow %
How rich?$5.7m$6m-$260.7k-4.5%

How much money is Acrux making?

Current yearPrevious yearGrowGrow %
Making money-$505.6k-$6.5m$6m1,187.2%
Net Profit Margin-9.1%-572.1%--

How much money comes from the company's main activities?

3. Financial Health of Acrux (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#712 / 992

Most Revenue
#325 / 992

Most Profit
#205 / 992

Most Efficient
#345 / 992

What can you expect buying and holding a share of Acrux? (5 min.)

Welcome investor! Acrux's management wants to use your money to grow the business. In return you get a share of Acrux.

What can you expect buying and holding a share of Acrux?

First you should know what it really means to hold a share of Acrux. And how you can make/lose money.

Speculation

The Price per Share of Acrux is A$0.077. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Acrux.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Acrux, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Acrux.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-2.3%0.00-2.3%-0.02-29.1%-0.02-24.3%0.00-1.0%
Usd Book Value Change Per Share0.00-1.2%0.00-1.2%-0.02-27.7%-0.01-12.6%-0.01-12.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.0110.8%
Usd Total Gains Per Share0.00-1.2%0.00-1.2%-0.02-27.7%-0.01-12.6%0.00-1.3%
Usd Price Per Share0.03-0.03-0.03-0.07-0.23-
Price to Earnings Ratio-15.98--15.98--1.54--6.28--24.28-
Price-to-Total Gains Ratio-30.99--30.99--1.61--7.44-178.33-
Price to Book Ratio1.40-1.40-1.66-2.17-3.15-
Price-to-Total Gains Ratio-30.99--30.99--1.61--7.44-178.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0509586
Number of shares19623
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (19623 shares)-17.60-190.07
Gains per Year (19623 shares)-70.40-760.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-70-800-760-770
20-141-1500-1521-1530
30-211-2200-2281-2290
40-282-2900-3041-3050
50-352-3600-3801-3810
60-422-4300-4562-4570
70-493-5000-5322-5330
80-563-5700-6082-6090
90-634-6400-6843-6850
100-704-7100-7603-7610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%8.014.01.034.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%9.014.00.039.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%3.00.07.030.0%6.00.017.026.1%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%13.010.00.056.5%

Fundamentals of Acrux

About Acrux Ltd

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-05-29 10:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Acrux Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Acrux earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†Acrux to the¬†Biotechnology industry mean.
  • A Net Profit Margin of -9.1%¬†means that¬†$-0.09 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acrux Ltd:

  • The MRQ is -9.1%. The company is making a loss. -1
  • The TTM is -9.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-9.1%0.0%
TTM-9.1%YOY-572.1%+563.0%
TTM-9.1%5Y-720.2%+711.1%
5Y-720.2%10Y-387.4%-332.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-178.5%+169.4%
TTM-9.1%-223.7%+214.6%
YOY-572.1%-245.1%-327.0%
5Y-720.2%-390.8%-329.4%
10Y-387.4%-503.2%+115.8%
1.1.2. Return on Assets

Shows how efficient Acrux is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Acrux to the¬†Biotechnology industry mean.
  • -5.3% Return on Assets means that¬†Acrux generated¬†$-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acrux Ltd:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-5.3%0.0%
TTM-5.3%YOY-64.4%+59.0%
TTM-5.3%5Y-41.4%+36.1%
5Y-41.4%10Y-15.1%-26.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-11.6%+6.3%
TTM-5.3%-11.6%+6.3%
YOY-64.4%-10.9%-53.5%
5Y-41.4%-12.9%-28.5%
10Y-15.1%-14.1%-1.0%
1.1.3. Return on Equity

Shows how efficient Acrux is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Acrux to the¬†Biotechnology industry mean.
  • -8.8% Return on Equity means Acrux generated $-0.09¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acrux Ltd:

  • The MRQ is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-8.8%0.0%
TTM-8.8%YOY-108.2%+99.4%
TTM-8.8%5Y-59.4%+50.6%
5Y-59.4%10Y-22.1%-37.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-13.9%+5.1%
TTM-8.8%-14.9%+6.1%
YOY-108.2%-13.5%-94.7%
5Y-59.4%-18.2%-41.2%
10Y-22.1%-19.0%-3.1%

1.2. Operating Efficiency of Acrux Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Acrux is operating .

  • Measures how much profit Acrux makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Acrux to the¬†Biotechnology industry mean.
  • An Operating Margin of -40.2%¬†means the company generated $-0.40 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acrux Ltd:

  • The MRQ is -40.2%. The company is operating very inefficient. -2
  • The TTM is -40.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-40.2%TTM-40.2%0.0%
TTM-40.2%YOY-754.3%+714.1%
TTM-40.2%5Y-1,006.5%+966.3%
5Y-1,006.5%10Y-504.9%-501.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.2%-344.0%+303.8%
TTM-40.2%-235.7%+195.5%
YOY-754.3%-262.3%-492.0%
5Y-1,006.5%-383.7%-622.8%
10Y-504.9%-485.1%-19.8%
1.2.2. Operating Ratio

Measures how efficient Acrux is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are $1.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acrux Ltd:

  • The MRQ is 1.402. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.402. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.402TTM1.4020.000
TTM1.402YOY11.865-10.463
TTM1.4025Y12.361-10.958
5Y12.36110Y6.939+5.421
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4023.092-1.690
TTM1.4023.353-1.951
YOY11.8653.564+8.301
5Y12.3614.836+7.525
10Y6.9396.187+0.752

1.3. Liquidity of Acrux Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Acrux is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 4.14¬†means the company has $4.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acrux Ltd:

  • The MRQ is 4.138. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.138. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.138TTM4.1380.000
TTM4.138YOY3.019+1.120
TTM4.1385Y5.436-1.297
5Y5.43610Y7.049-1.614
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1383.776+0.362
TTM4.1384.034+0.104
YOY3.0194.978-1.959
5Y5.4365.984-0.548
10Y7.0496.360+0.689
1.3.2. Quick Ratio

Measures if Acrux is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Acrux to the¬†Biotechnology industry mean.
  • A Quick Ratio of 3.99¬†means the company can pay off $3.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acrux Ltd:

  • The MRQ is 3.991. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.991. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.991TTM3.9910.000
TTM3.991YOY2.892+1.099
TTM3.9915Y5.111-1.120
5Y5.11110Y6.856-1.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9913.198+0.793
TTM3.9913.631+0.360
YOY2.8924.843-1.951
5Y5.1115.825-0.714
10Y6.8566.378+0.478

1.4. Solvency of Acrux Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Acrux assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Acrux to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.39¬†means that Acrux assets are¬†financed with 39.2% credit (debt) and the remaining percentage (100% - 39.2%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Acrux Ltd:

  • The MRQ is 0.392. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.392. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.392TTM0.3920.000
TTM0.392YOY0.405-0.013
TTM0.3925Y0.288+0.103
5Y0.28810Y0.214+0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3920.336+0.056
TTM0.3920.346+0.046
YOY0.4050.284+0.121
5Y0.2880.367-0.079
10Y0.2140.376-0.162
1.4.2. Debt to Equity Ratio

Measures if Acrux is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Acrux to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 64.4% means that company has $0.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acrux Ltd:

  • The MRQ is 0.644. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.644. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.644TTM0.6440.000
TTM0.644YOY0.680-0.036
TTM0.6445Y0.438+0.206
5Y0.43810Y0.303+0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6440.382+0.262
TTM0.6440.421+0.223
YOY0.6800.371+0.309
5Y0.4380.447-0.009
10Y0.3030.476-0.173

2. Market Valuation of Acrux Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Acrux generates.

  • Above 15 is considered overpriced but¬†always compare¬†Acrux to the¬†Biotechnology industry mean.
  • A PE ratio of -15.98 means the investor is paying $-15.98¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acrux Ltd:

  • The EOD is -29.300. Based on the earnings, the company is expensive. -2
  • The MRQ is -15.982. Based on the earnings, the company is expensive. -2
  • The TTM is -15.982. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-29.300MRQ-15.982-13.318
MRQ-15.982TTM-15.9820.000
TTM-15.982YOY-1.537-14.445
TTM-15.9825Y-6.285-9.697
5Y-6.28510Y-24.284+18.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-29.300-2.473-26.827
MRQ-15.982-2.865-13.117
TTM-15.982-2.837-13.145
YOY-1.537-3.461+1.924
5Y-6.285-6.135-0.150
10Y-24.284-6.468-17.816
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Acrux Ltd:

  • The EOD is 38.331. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 20.908. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.908. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD38.331MRQ20.908+17.423
MRQ20.908TTM20.9080.000
TTM20.908YOY-1.628+22.536
TTM20.9085Y1.198+19.710
5Y1.19810Y5.615-4.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD38.331-3.046+41.377
MRQ20.908-3.513+24.421
TTM20.908-3.609+24.517
YOY-1.628-4.805+3.177
5Y1.198-7.882+9.080
10Y5.615-8.502+14.117
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Acrux is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of 1.40 means the investor is paying $1.40¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acrux Ltd:

  • The EOD is 2.574. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.404. Based on the equity, the company is underpriced. +1
  • The TTM is 1.404. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.574MRQ1.404+1.170
MRQ1.404TTM1.4040.000
TTM1.404YOY1.663-0.259
TTM1.4045Y2.169-0.765
5Y2.16910Y3.147-0.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.5742.012+0.562
MRQ1.4042.185-0.781
TTM1.4042.227-0.823
YOY1.6632.447-0.784
5Y2.1693.726-1.557
10Y3.1474.199-1.052
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Acrux Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Acrux Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%-0.032+2281%-0.015+980%-0.014+939%
Book Value Per Share--0.0300.0300%0.031-4%0.049-39%0.093-68%
Current Ratio--4.1384.1380%3.019+37%5.436-24%7.049-41%
Debt To Asset Ratio--0.3920.3920%0.405-3%0.288+36%0.214+83%
Debt To Equity Ratio--0.6440.6440%0.680-5%0.438+47%0.303+113%
Dividend Per Share----0%-0%-0%0.013-100%
Eps---0.003-0.0030%-0.034+1187%-0.028+974%-0.001-56%
Free Cash Flow Per Share--0.0020.0020%-0.032+1690%-0.027+1447%0.008-74%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.032+2454%-0.015+1217%-0.006+528%
Gross Profit Margin--2.2982.2980%1.713+34%1.803+27%2.336-2%
Intrinsic Value_10Y_max--0.549--------
Intrinsic Value_10Y_min---0.272--------
Intrinsic Value_1Y_max--0.018--------
Intrinsic Value_1Y_min---0.027--------
Intrinsic Value_3Y_max--0.082--------
Intrinsic Value_3Y_min---0.083--------
Intrinsic Value_5Y_max--0.181--------
Intrinsic Value_5Y_min---0.138--------
Market Cap22385208.384+45%12210113.66412210113.6640%15117283.584-19%32211442.714-62%101431158.509-88%
Net Profit Margin---0.091-0.0910%-5.721+6212%-7.202+7846%-3.874+4174%
Operating Margin---0.402-0.4020%-7.543+1775%-10.065+2403%-5.049+1155%
Operating Ratio--1.4021.4020%11.865-88%12.361-89%6.939-80%
Pb Ratio2.574+45%1.4041.4040%1.663-16%2.169-35%3.147-55%
Pe Ratio-29.300-83%-15.982-15.9820%-1.537-90%-6.285-61%-24.284+52%
Price Per Share0.077+45%0.0420.0420%0.052-19%0.111-62%0.349-88%
Price To Free Cash Flow Ratio38.331+45%20.90820.9080%-1.628+108%1.198+1645%5.615+272%
Price To Total Gains Ratio-56.815-83%-30.990-30.9900%-1.611-95%-7.442-76%178.327-117%
Quick Ratio--3.9913.9910%2.892+38%5.111-22%6.856-42%
Return On Assets---0.053-0.0530%-0.644+1105%-0.414+675%-0.151+183%
Return On Equity---0.088-0.0880%-1.082+1131%-0.594+576%-0.221+152%
Total Gains Per Share---0.001-0.0010%-0.032+2281%-0.015+980%-0.001+9%
Usd Book Value--5755012.8005755012.8000%6015762.000-4%9403119.120-39%17968465.620-68%
Usd Book Value Change Per Share---0.001-0.0010%-0.021+2281%-0.010+980%-0.009+939%
Usd Book Value Per Share--0.0200.0200%0.021-4%0.032-39%0.062-68%
Usd Dividend Per Share----0%-0%-0%0.008-100%
Usd Eps---0.002-0.0020%-0.022+1187%-0.019+974%-0.001-56%
Usd Free Cash Flow--386491.200386491.2000%-6144151.200+1690%-5205057.000+1447%1515455.820-74%
Usd Free Cash Flow Per Share--0.0010.0010%-0.021+1690%-0.018+1447%0.005-74%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.021+2454%-0.010+1217%-0.004+528%
Usd Market Cap14814530.909+45%8080653.2238080653.2230%10004618.276-19%21317532.788-62%67127140.701-88%
Usd Price Per Share0.051+45%0.0280.0280%0.034-19%0.073-62%0.231-88%
Usd Profit---505615.200-505615.2000%-6508141.200+1187%-5429804.148+974%-222827.994-56%
Usd Revenue--5578312.2005578312.2000%1137634.200+390%1769520.840+215%9828987.420-43%
Usd Total Gains Per Share---0.001-0.0010%-0.021+2281%-0.010+980%-0.001+9%
 EOD+4 -4MRQTTM+0 -0YOY+26 -85Y+22 -1210Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Acrux Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-29.300
Price to Book Ratio (EOD)Between0-12.574
Net Profit Margin (MRQ)Greater than0-0.091
Operating Margin (MRQ)Greater than0-0.402
Quick Ratio (MRQ)Greater than13.991
Current Ratio (MRQ)Greater than14.138
Debt to Asset Ratio (MRQ)Less than10.392
Debt to Equity Ratio (MRQ)Less than10.644
Return on Equity (MRQ)Greater than0.15-0.088
Return on Assets (MRQ)Greater than0.05-0.053
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Acrux Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.013
Ma 20Greater thanMa 500.073
Ma 50Greater thanMa 1000.067
Ma 100Greater thanMa 2000.062
OpenGreater thanClose0.078
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Gross Profit  -4,492733-3,759-3,832-7,5912,939-4,6526,5981,946
Total Other Income Expense Net 4,655-4,29036533398-38018-217-199



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets14,299
Total Liabilities5,603
Total Stockholder Equity8,696
 As reported
Total Liabilities 5,603
Total Stockholder Equity+ 8,696
Total Assets = 14,299

Assets

Total Assets14,299
Total Current Assets9,891
Long-term Assets4,408
Total Current Assets
Cash And Cash Equivalents 6,232
Net Receivables 3,306
Other Current Assets 353
Total Current Assets  (as reported)9,891
Total Current Assets  (calculated)9,891
+/-0
Long-term Assets
Property Plant Equipment 2,591
Other Assets 0
Long-term Assets  (as reported)4,408
Long-term Assets  (calculated)2,591
+/- 1,817

Liabilities & Shareholders' Equity

Total Current Liabilities2,390
Long-term Liabilities3,213
Total Stockholder Equity8,696
Total Current Liabilities
Short-term Debt 192
Accounts payable 488
Other Current Liabilities 1,710
Total Current Liabilities  (as reported)2,390
Total Current Liabilities  (calculated)2,390
+/-0
Long-term Liabilities
Long term Debt Total 2,161
Other Liabilities 38
Long-term Liabilities  (as reported)3,213
Long-term Liabilities  (calculated)2,199
+/- 1,014
Total Stockholder Equity
Common Stock114,884
Retained Earnings -114,487
Accumulated Other Comprehensive Income 8,299
Other Stockholders Equity 0
Total Stockholder Equity (as reported)8,696
Total Stockholder Equity (calculated)8,696
+/-0
Other
Capital Stock114,884
Cash And Equivalents3,000
Cash and Short Term Investments 6,232
Common Stock Shares Outstanding 286,461
Current Deferred Revenue-192
Liabilities and Stockholders Equity 14,299
Net Debt -3,879
Net Invested Capital 8,696
Net Tangible Assets 8,696
Net Working Capital 7,501
Property Plant and Equipment Gross 5,494
Short Long Term Debt Total 2,353



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-30
> Total Assets 
12,019
18,356
12,846
9,758
31,094
23,234
20,369
41,267
34,950
83,605
58,995
58,499
52,895
53,221
48,495
53,371
47,306
32,490
24,433
18,521
24,202
15,273
14,299
14,29915,27324,20218,52124,43332,49047,30653,37148,49553,22152,89558,49958,99583,60534,95041,26720,36923,23431,0949,75812,84618,35612,019
   > Total Current Assets 
0
18,046
11,565
7,510
28,559
20,682
18,018
34,990
15,347
59,173
34,102
33,880
29,665
31,379
28,011
34,143
39,597
28,961
20,940
12,342
18,594
10,016
9,891
9,89110,01618,59412,34220,94028,96139,59734,14328,01131,37929,66533,88034,10259,17315,34734,99018,01820,68228,5597,51011,56518,0460
       Cash And Cash Equivalents 
11,590
17,848
10,830
6,564
28,068
19,739
17,227
34,366
14,736
58,609
33,159
30,017
22,840
25,775
23,068
29,360
33,974
28,470
18,152
9,206
15,270
5,831
6,232
6,2325,83115,2709,20618,15228,47033,97429,36023,06825,77522,84030,01733,15958,60914,73634,36617,22719,73928,0686,56410,83017,84811,590
       Net Receivables 
360
125
68
67
302
690
626
437
474
446
880
3,718
6,591
5,347
4,760
4,561
5,487
155
198
2,559
3,159
3,765
3,306
3,3063,7653,1592,5591981555,4874,5614,7605,3476,5913,7188804464744376266903026768125360
       Inventory 
0
0
135
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,369
-2,871
0
316
3160-2,871-2,36900000000000000010813500
   > Long-term Assets 
0
310
1,281
2,248
2,535
2,552
2,351
6,277
19,603
24,432
24,893
24,619
439
329
248
324
778
845
906
6,179
5,608
5,257
4,408
4,4085,2575,6086,17990684577832424832943924,61924,89324,43219,6036,2772,3512,5522,5352,2481,2813100
       Property Plant Equipment 
55
310
1,281
1,039
1,157
1,248
1,052
1,201
2,376
23,801
24,357
24,178
93
78
92
262
778
845
906
3,100
2,644
2,556
2,591
2,5912,5562,6443,10090684577826292789324,17824,35723,8012,3761,2011,0521,2481,1571,0391,28131055
       Intangible Assets 
0
0
0
1,200
1,142
1,059
988
4,823
16,974
631
536
441
346
251
156
62
6,839
803
696
589
482
375
0
03754825896968036,8396215625134644153663116,9744,8239881,0591,1421,200000
       Other Assets 
0
0
0
0
236
245
311
4,447
17,105
22,777
24,231
24,068
22,791
21,513
20,236
18,904
6,931
2,684
2,587
2,394
2,089
1,730
0
01,7302,0892,3942,5872,6846,93118,90420,23621,51322,79124,06824,23122,77717,1054,4473112452360000
> Total Liabilities 
741
870
1,181
1,349
1,612
2,651
2,123
3,158
3,727
3,136
13,283
5,396
3,262
11,164
7,870
9,482
3,381
2,519
2,497
5,672
5,731
6,183
5,603
5,6036,1835,7315,6722,4972,5193,3819,4827,87011,1643,2625,39613,2833,1363,7273,1582,1232,6511,6121,3491,181870741
   > Total Current Liabilities 
741
870
1,181
1,327
1,581
2,600
2,061
3,074
3,681
1,975
7,736
1,878
3,262
6,056
3,202
5,738
3,362
2,484
2,416
2,665
2,766
3,318
2,390
2,3903,3182,7662,6652,4162,4843,3625,7383,2026,0563,2621,8787,7361,9753,6813,0742,0612,6001,5811,3271,181870741
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167
167
185
224
192
192224185167167000000000000000000
       Accounts payable 
680
503
956
880
603
833
549
642
1,089
321
218
193
135
217
106
606
564
731
901
1,025
312
789
488
4887893121,0259017315646061062171351932183211,089642549833603880956503680
       Other Current Liabilities 
61
367
225
447
978
1,767
1,512
2,432
2,592
1,654
7,518
1,685
3,127
5,839
3,096
5,132
2,798
1,753
1,515
1,473
2,269
2,305
1,710
1,7102,3052,2691,4731,5151,7532,7985,1323,0965,8393,1271,6857,5181,6542,5922,4321,5121,76797844722536761
   > Long-term Liabilities 
0
0
0
22
31
51
62
84
46
1,161
5,547
3,518
2,880
5,108
4,668
5,392
2,129
35
552
3,007
2,965
2,865
3,213
3,2132,8652,9653,007552352,1295,3924,6685,1082,8803,5185,5471,161468462513122000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,234
2,049
1,854
2,161
2,1611,8542,0492,2340000000000000000000
       Other Liabilities 
0
0
0
22
31
51
62
84
46
67
52
14
20
11
4,668
3,744
19
35
81
88
41
40
38
384041888135193,7444,6681120145267468462513122000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
21,513
20,236
18,904
6,839
803
696
589
482
375
0
03754825896968036,83918,90420,23621,5130000000000000
> Total Stockholder Equity
11,278
17,485
11,638
8,385
29,482
20,582
18,246
38,109
31,223
80,469
45,712
53,103
46,753
42,057
40,625
43,889
43,925
29,971
21,936
12,849
18,471
9,090
8,696
8,6969,09018,47112,84921,93629,97143,92543,88940,62542,05746,75353,10345,71280,46931,22338,10918,24620,58229,4828,38511,63817,48511,278
   Common Stock
15,338
24,689
24,789
25,766
52,883
53,340
58,813
83,135
83,211
85,786
95,825
95,825
95,873
95,873
95,873
95,873
95,873
95,873
95,879
96,137
114,213
114,563
114,884
114,884114,563114,21396,13795,87995,87395,87395,87395,87395,87395,87395,82595,82585,78683,21183,13558,81353,34052,88325,76624,78924,68915,338
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 
0
-70
-314
-543
-873
2,106
59,823
1,570
1,953
2,061
4
4
-1,190
638
1,194
1,454
1,215
581
639
582
8,147
8,250
8,299
8,2998,2508,1475826395811,2151,4541,194638-1,190442,0611,9531,57059,8232,106-873-543-314-700
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
70
314
567
873
3,329
-58,813
2,764
3,413
3,713
1,462
1,448
1,190
726
2,434
2,760
2,506
2,100
2,477
2,797
757
860
0
08607572,7972,4772,1002,5062,7602,4347261,1901,4481,4623,7133,4132,764-58,8133,329873567314700



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.